ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Consensus Conference Agenda, Registration Online.

September 1, 2000

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

NIH Forming Special Emphasis Panel To Review Clinical Oncology Grants

September 18, 1998

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

ASCO Backs Sentinel Node Biopsy In Some Early Stage Breast Cancer

September 30, 2005